Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.140
+0.080 (7.55%)
At close: Apr 13, 2026, 4:00 PM EDT
1.070
-0.070 (-6.14%)
After-hours: Apr 13, 2026, 4:33 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $5.73 million as of April 13, 2026. Its market cap has decreased by -99.95% in one year.
Market Cap
5.73M
Enterprise Value
9.90M
1-Year Change
-99.95%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $5.73M, a decrease of -98.36%. That is a compound annual growth rate of -64.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 5.33M | -62.43% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 5.73M |
| Ernexa Therapeutics | 5.69M |
| Bio Green Med Solution | 5.57M |
| CollPlant Biotechnologies | 5.51M |
| Cardio Diagnostics Holdings | 5.42M |
| Mustang Bio | 5.30M |
| Aptevo Therapeutics | 5.25M |
| Moolec Science | 5.16M |